Crypto US stocks, including Circle (CRCL), Galaxy Digital (GLXY), and Core Scientific (CORZ), are showing mixed performance as they react to recent market events.
CRCL made a historic public debut with a significant surge, while GLXY faces a dip despite strong analyst optimism. Meanwhile, CORZ has demonstrated strong recent gains, supported by favorable analyst ratings.
Circle (CRCL), the issuer of the USDC stablecoin, achieved a historic milestone by becoming the first stablecoin company to list publicly on the New York Stock Exchange.
Debuting at $31 per share, CRCL experienced an explosive surge of over 200% on its first day, reaching $100. Despite opening down more than 5% today, it is currently trading around $109.
The Initial Public Offering (IPO) successfully raised $1.1 billion, valuing the company at $6.9 billion, and showing strong investor confidence. CEO Jeremy Allaire emphasized the listing as pivotal in Circle’s enduring mission to revolutionize global finance.
Following this significant IPO, major players in the investment world quickly reacted: ProShares and Bitwise have already submitted proposals to the SEC for the creation of new Exchange Traded Funds (ETFs) designed to track Circle’s stock performance, further validating the market’s interest in this new public entity.
For CRCL’s immediate price trajectory, a crucial support level lies at $106; if this level is breached, the stock could potentially decline to $76.
Conversely, if CRCL can re-establish an uptrend, it may challenge the resistance at $123, and a successful break above this point could see its price climb further to $138.
Galaxy Digital (GLXY) is currently experiencing a dip, down approximately 2% today and nearly 13% since its Nasdaq debut. Despite this recent performance, market analysts maintain a highly optimistic outlook for the company.
A consensus of nine analysts providing a one-year forecast projects an average upside of 36.23% for GLXY, setting a price target of $27.85.
Notably, all nine analysts have issued a “Strong Buy” rating, reflecting strong conviction in the company’s future growth potential.
GLXY recently faced a hurdle, failing to break through the resistance level at $21.2. Should the stock re-test this resistance and successfully break above it, it could pave the way for a rally to $24.99.
Conversely, if the current downward correction persists, GLXY might test the support level at $18.96.
A failure to hold this support could lead to a further decline, potentially pushing the price down to $17.99.
Core Scientific (CORZ) has demonstrated significant upward momentum recently, climbing over 35% in the last 30 days and more than 7% in the past five days alone.
This strong performance is met with considerable optimism from financial analysts. A consensus of 17 analysts providing a one-year forecast projects an impressive average upside of 44.55% for CORZ, setting a price target of $18.21.
Furthermore, 17 out of 18 analysts have issued either a “Strong Buy” or “Buy” rating, indicating widespread confidence in the company’s prospects.
CORZ is currently trading near a key resistance level at $13.18. A successful breach of this resistance could propel the stock higher, potentially reaching $16.63.
Conversely, if the support level at $11.33 is tested and fails to hold, CORZ could face a notable downturn, potentially falling to $9.45. In a more pronounced downtrend, the stock might even decline to $7.99.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。